Table 1.

The relationship between cancer treatment and the prevalence of COVID 19

Cancer	Breast cancer	Colon cancer	Gastric cancer	Lung cancer	Ovarian cancer	GBMc	Pancreaticobilliary tumor
Number Patients	92	72	19	11	12	5	10
Stage I	5
Stage II	29	9	4		2
Stage III	37	35	10		6
Stage IV	21	21	5		4
Treatment	CHTb Trastuzumab	CHTb Bevacisumab Cetuximab	CHTb	CHTb Erlotinib	CHTb	PVCd Temozolomide	CHTb
COVID 19 RT-PCR	0	1	0	1	0	1	0
Suspicious in HRCT SCAN	0	1	0	1	1	1	0
Death due COVID 19	0	1	0	1a	0	1	0
Progression of Malignancy	0	0	0	0	0	0	0
Treatment method	Q3f weeks	Q2e weeks	Q3 weeks	Q3 weeks	Q3 weeks	Daily	Q3 weeks

^aNo treatment for malignancy

^bCHT: chemotherapy

^cGBM: glioblastoma multiform

^dProcarbazine, lomustine (CCNU), and vincristine (PCV)

^eQ2 weeks: once every 2 weeks

^fQ3 weeks: once every 3 weeks